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nephrolithotripsyAbstract Background: Percutaneous nephrolithotripsy is a technique used for the treatment of
renal stones during which an irrigation ﬂuid is used which may cause hypothermia and shivering
if not prevented. The aim of this prospective randomized placebo controlled double blinded study
was designed to evaluate the efﬁcacy of preoperative hydrocortisone versus tramadol for attenua-
tion of postoperative shivering after percutaneous nephrolithotripsy under general anesthesia
Method: 90 ASA I males and females patients aged 20–50 years, planned for percutaneous nephro-
lithotripsy under general anesthesia were randomly divided into three groups:
Group S (n= 30) received 10 ml normal saline IV before induction of general anesthesia
Group H (n= 30) received IV hydrocortisone 2 mg/kg before induction of general anesthesia
GroupT (n= 30) received IV tramadol hydrochloride 1 mg/kg before induction of general anesthesia
The following parameters were recorded:
Core temperature, heart rate and mean arterial blood pressure before induction of anesthesia, then
every 15 min after induction of anesthesia, and every 30 min in the PACU, shivering intensity in the
ﬁrst 2 h postoperative, the incidence of shivering, the number of patients requiredmeperidine and side
effects.
Results: The number of patients who had shivering was statistically signiﬁcantly higher in S group
(12) than in H group (8) and in T group (7) with no statistically signiﬁcant differences between H
and T groups.
Intraoperative heart rate, mean arterial blood pressure and side effects showed no statistically signif-
icant difference between the study groups.
222 D.A. Rashwan et al.Conclusion: Preoperative IV hydrocortisone and tramadol were effective in attenuation of postoper-
ative shivering compared to placebo after percutaneous nephrolithotripsy without increasing the inci-
dence of side effects.
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Body core temperature is important for the maintenance of
normal physiology of the body, and intraoperative hypother-
mia causes postoperative shivering, coagulation disorders,
and prolongation of drug duration [1].
General anesthesia facilitates redistribution of the tempera-
ture from the central tissues to the peripheral tissues [2] causing
perioperative hypothermia which complicates a large percent-
age of surgeries [3].
Percutaneous nephrolithotripsy (PCNL) is a common tech-
nique for the treatment of renal stones [4], and the use of irri-
gation ﬂuid during endoscopic surgeries at room temperature
may lead to hypothermia and shivering [5].
Malhotra et al. reported that ﬂuid absorption occurred in
78% of the PCNL, and this may lead to inadvertent intraoper-
ative hypothermia [6] and postoperative shivering which
increase oxygen consumption, blood pressure, and intracranial
and intraocular pressures [7].
Many drugs such as meperidine, ondansetron and clonidine
have been used for the prevention of shivering [8].
Hydrocortisone has been found to be effective in the
prevention of postoperative shivering after general anesthesia
[9].
Tramadol hydrochloride, a synthetic opioid, prevents shiv-
ering by inhibiting the reuptake of serotonine, dopamine and
norepinephrine [10], and previous studies showed that tra-
madol is a potent prophylactic antishivering agent [11–13].
The aim of this prospective randomized placebo controlled
double blinded study was to evaluate the efﬁcacy of preopera-
tive hydrocortisone versus tramadol for attenuation of postop-
erative shivering after percutaneous nephrolithotripsy under
general anesthesia.2. Patients and methods
After approval from the ethical committee in Faculty of med-
icine, Beni suef university hospital (FMBSU REC, Egypt), the
study was registered at the Australian New Zealand Clinical
Trials Registry (ANZCTR), the registration number is
ACTRN12614000413628, and written informed consents were
obtained from 90 ASA I male and female patients aged 20–
50 years, who were planned for percutaneous nephrolitho-
tripsy under general anesthesia from May 2014 to January
2015.
Patients were excluded from the study if they are ASA > I,
had history of peptic ulcer, or are on prolonged steroid ther-
apy, and those with history of use of antidepressant drugs, epi-
lepsy, a known allergy to the study drugs, expected blood
transfusion during surgery, BMI > 30 or an initial body tem-
perature >38 C or <36 C were also excluded.
On arrival to the operating theater, 18 G intravenous can-
nula was inserted and IV warmed crystalloid ﬂuid was infused.The patients were randomly divided using closed envelope
technique for randomization to one of three groups:
Group S (n= 30): received 10 ml normal saline IV.
Group H (n= 30): received IV hydrocortisone 2 mg/kg.
Group T (n= 30): received IV tramadol hydrochloride
1 mg/kg.
The studied drugs were diluted in 10 ml coded syringes and
given as an IV bolus just before induction of general anesthesia
by an anesthesiologist who is unaware of the study protocol.
With adjustment of the temperature in operating room at
22 C 24 C, the monitor was attached to the patients to take
preoperative readings of heart rate, non-invasive arterial blood
pressure, and SpO2.
General anesthesia was induced after preoxygenation for 3–
5 min with 100% oxygen by face mask, then anesthesia was
induced in all patients with the use of IV fentanyl 2 lg/kg,
IV propofol 1.5–2 mg/kg, and atracurium 0.5 mg/kg and they
were ventilated manually with sevoﬂorane 2 volume%, 100%
oxygen via a face mask and then oral cuffed endotracheal tube
was inserted. Muscle relaxation was guided by nerve stimula-
tor anesthesia was maintained with oxygen 100%, sevoﬂorane,
additional doses of atracurium, and mechanical ventilation
with maintenance of end tidal carbon dioxide 35–40 mmHg.
The patients were covered with sheets and sterile surgical
drapes, and all intravenous ﬂuids and irrigation ﬂuids were
warmed.
At the end of surgery, neuromuscular blockade was
reversed with IV neostigmine 0.04 mg/kg and atropine
0.02 mg/kg, the trachea was extubated when the patient
responds to commands, and all patients were transferred to
PACU, where they received oxygen via face mask 3–4 l/min
and were monitored and covered with cotton blanket.
The following parameters were recorded by senior anesthe-
sia resident unaware of the study protocol:
1. Patient characteristics and operation time.
2. Core temperature (C) (tympanic membrane temperature
by Rossmax medical infrared ear thermometer, radiant
innovation Inc., Taiwan) before induction of anesthesia,
then every 15 min after induction of anesthesia, and every
30 min in the PACU.
3. Shivering intensity in the ﬁrst 2 h postoperative was graded
by using a ﬁve-point scale that was used in the study of
Honarmand and Safavi [8].
(Grade 0: none; Grade 1: one or more areas of Pilo erection
but without visible muscular activity; Grade 2: visible mus-
cular activity conﬁned to one muscle group; Grade 3: same
as Grade 2 but in more than one muscle group; and Grade
4: gross muscular activity involving the entire body). If
grades 3 shivering was observed the patients were treated
with IV meperidine 25 mg.
Enrollment 
Randomized (n=90 ) 
Excluded (n=0)
♦ Not meeting inclusion criteria (n=0 ) 
♦ Declined to participate (n= 0 )
♦ Other reasons (n= 0)
Assessed for eligibility (n=90) 
Allocated to S group (n= 30)
♦ Received allocated intervention 
(n=30  )
♦ Did not receive allocated
intervention (n= 0)
Allocation
Allocated to H group (n= 30)
♦ Received allocated 
intervention (n= 30)
♦ Did not receive allocated
intervention (n= 0)
Allocated to T group (n=30)
♦ Received allocated 
intervention (n= 30)
♦ Did not receive allocated
intervention (n=0 )
Analysed (n=30 ) 
♦ Excluded from analysis
(n=0 )
Analysed (n=30)
♦ Excluded from analysis (n= 0 )
Lost to follow-up (n=0  )
Discontinued
intervention (n= 0) 
Analysis
Analysed (n=30)
♦ Excluded from
analysis (n=0)
Follow-Up
Lost to follow-up (n= 0)
Discontinued intervention (n= 0) 
Lost to follow-up (n= 0 )
Discontinued intervention (n= 0)
Figure 1 90 patients completed the study.
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5. Number of patients requiring meperidine.
6. Heart rate and mean arterial blood pressure were recorded
before anesthesia, every 15 min after anesthesia, and every
30 min in the recovery room.
7. Side effects:
– Nausea and vomiting:
– Hypotension (decrease in MAP> 20% from preopera-
tive reading).
– hypertension (increase in MAP > 20% from preopera-
tive reading).
– tachycardia (increase in HR> 20% from preoperative
reading).3. Statistical analysis
Data are presented as mean and standard deviation (SD) or
median (range) or numbers as appropriate, and parametric
data were analyzed using one way ANOVA. Nonparametric
data were analyzed by using the Kruskal–Wallis test. P values
<0.05 were considered statistically signiﬁcant, and the
signiﬁcance of the differences in three sample means is
being evaluated using F-test (ANOVA). The alpha level is
a= 0.05 and the power is 0.90 using G Power program.
Statistical package for social science (SPSS) software version
15 was used.
Table 3 Incidence, severity of shivering and number of
patients received meperidine. Data are presented as numbers
(%).
Variables S
(n= 30)
H
(n= 30)
T
(n= 30)
Patients developed shivering no
(%)
12 (40)* 8 (26.6) 7 (20)
Grades of shivering
Grade 0 18 22 23
Grade 1 5 3 2
Grade 2 2 2 3
Grade 3 5 3 2
Grade 4 0 0 0
Patients received meperidine(n) 5 3 2
Group S: received 10 ml normal saline IV.
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All patients completed the study, ﬂow diagram Fig. 1.
Patient’s characteristics and operative data showed no sta-
tistically signiﬁcant difference between the studied groups,
Table 1.
Core temperature showed no statistically signiﬁcant differ-
ence between the study groups, Table 2.
Number of Patients developed shivering was statistically
signiﬁcantly higher in S group (12) than in H group (8) and
T group (7) with no statistically signiﬁcant difference between
H and T groups.
Number of patients had grade 0 shivering was higher in
groups H and T compared to group S with no statistically signif-
icant difference between the three groups, grade 3 shivering was
higher in group compared to group H and group T, no patientTable 1 Demographic data, duration of operation. Data are
presented as mean ± SD, numbers.
Variables S (n= 30) H (n= 30) T (n= 30)
Age (year) 35.1 ± 8.92 32.66 ± 7.93 34.76 ± 10.41
Weight (kg) 83.93 ± 6.50 82.13 ± 8.32 84.53 ± 7.67
Height (cm) 165.2 ± 7.35 164.56 ± 7.52 164.2 ± 7.077
Sex (male/
female)
19/11 18/12 20/10
Duration of
operation (min)
101.83 ± 10.46 100 ± 10.82 101 ± 11.24
Group S: received 10 ml normal saline IV.
Group H: received IV hydrocortisone 2 mg/kg.
Group T: received IV tramadol hydrochloride 1 mg/kg
No statistically signiﬁcant difference between the study groups,
P value >0.05.
Table 2 Core temperature C. Data are presented as
mean ± SD.
S (n= 30) H (n= 30) T (n= 30)
Temperature
Preoperative 36.95 ± 0.15 36.93 ± 0.17 36.88 ± 0.21
15 min 36.72 ± 0.42 36.87 ± 0.31 36.88 ± 0.30
30 min 36.77 ± 0.39 36.66 ± 0.43 36.5 ± 0.48
45 min 36.69 ± 0.44 36.89 ± 0.27 36.87 ± 0.30
60 min 36.65 ± 0.45 36.79 ± 0.40 36.84 ± 0.34
75 min 36.66 ± 0.47 36.84 ± 0.35 36.85 ± 0.34
90 min 36.07 ± 0.44 36.44 ± 0.48 36.45 ± 0.49
105 min 35.86 ± 0.41 36.11 ± 0.39 36.39 ± 0.44
PACU
0 min 35.95 ± 0.15 36.03 ± 0.17 36.0 ± 0.20
30 min 36.01 ± 0.42 36.87 ± 0.31 36.88 ± 0.30
60 min 36.65 ± 0.47 36.79 ± 0.37 36.83 ± 0.35
90 min 36.71 ± 0.42 36.8 ± 0.31 36.88 ± 0.30
120 min 36.81 ± 0.38 36.90 ± 0.26 36.92 ± 0.25
Group S: received 10 ml normal saline IV.
Group H: received IV hydrocortisone 2 mg/kg.
Group T: received IV tramadol hydrochloride 1 mg/kg.
No statistically signiﬁcant difference between the study groups,
P value >0.05.
Group H: received IV hydrocortisone 2 mg/kg.
Group T: received IV tramadol hydrochloride 1 mg/kg.
No statistically signiﬁcant difference between the study groups,
P value >0.05.had grade 4 shivering, and number of patients received meperi-
dine was lower in groups H and T compared to group S. Table 3.
Intraoperative heart rate, mean arterial blood pressure and
side effects showed no statistically signiﬁcant differences
between the study groups Tables 4–6.
5. Discussion
Postanesthetic shivering is common after general anesthesia
with an incidence up to 60% [11], and it can cause rise in oxy-
gen consumption and increase in intraocular and intracranial
pressures[12].
Postanesthetic shivering may occur due to unintended
intraoperative hypothermia which may be due to a cool oper-
ating room, infusion of cool ﬂuids, and the effects of anesthetic
drugs [14].
The results of the present study showed that preoperative
IV hydrocortisone and tramadol were effective in attenuation
of postoperative shivering compared to placebo after percuta-
neous nephrolithotripsy without increasing the incidence of
side effects.
In the present study preoperative IV tramadol hydrochlo-
ride 1 mg/kg was effective in attenuation of postoperative shiv-
ering compared to placebo without increasing g the incidence
of side effects.
The efﬁcacy of tramadol in prevention of postoperative
shivering was investigated in many studies using different
doses and regimes.
Angral et al. [10] showed that IV tramadol 1 mg/kg given at
the end of the operation was effective in reducing the incidence
and severity of shivering after open and laparoscopic cholecys-
tectomy compared to placebo without increasing the incidence
of side effects.
Mathews et al. [11] concluded that intravenous tramadol
2 mg/kg and 1 mg/kg given at the time of wound closure were
effective in prevention of postanesthetic shivering after general
anesthesia compared to placebo without increasing the inci-
dence of side effects as vomiting. In the high-dose group, 2%
Table 4 Heart rate (Bpm). Data are presented as mean ± SD.
Variable S (n= 30) H (n= 30) T (n= 30)
Preinduction 78.9 ± 6.99 76.13 ± 6.90 77.06 ± 6.79
15 min 79.5 ± 7.79 76.46 ± 6.17 77.83 ± 6.59
30 min 74.86 ± 6.16 73.3 ± 7.92 74.3 ± 7.11
45 min 76.53 ± 4.59 74.96 ± 4.70 74.66 ± 5.61
60 min 72.8 ± 7.00 72.5 ± 5.13 71.8 ± 6.52
75 min 74.76 ± 4.65 72.83 ± 3.92 73 ± 4.07
90 min 75.23 ± 5.32 72.7 ± 4.91 72.9 ± 5.35
105 min 74.86 ± 4.53 73.2 ± 4.75 73.3 ± 4.88
PACU
0 min 80.3 ± 7.52. 77.43 ± 6.27 78.46 ± 6.32
30 min 79.9 ± 7.43 76.96 ± 5.81 78.23 ± 6.33
60 min 80.2 ± 7.57 77.56 ± 5.78 78.5 ± 6.57
90 min 79.5 ± 7.61 76.86 ± 6.17 78.06 ± 6.38
120 min 74.53 ± 4.55 72.76 ± 6.59 72.63±4.70
Group S: received 10 ml normal saline IV.
Group H: received IV hydrocortisone 2 mg/kg.
Group T: received IV tramadol hydrochloride 1 mg/kg.
No statistically signiﬁcant difference between the study groups,
P value >0.05.
Table 6 Side effects. Data are presented as numbers.
Variable S (n= 30) H (n= 30) T (n= 30)
Nausea 2 1 3
Vomiting 0 0 1
Hypotension 0 0 0
Hypertension 0 0 0
Tachycardia 0 0 0
Group S: received 10 ml normal saline IV.
Group H: received IV hydrocortisone 2 mg/kg.
Group T: received IV tramadol hydrochloride 1 mg/kg.
No statistically signiﬁcant difference between the study groups,
P value >0.05.
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the low-dose group and 48% in the control group.
A study by Enakshi et al. [12] concluded that IV tramadol
1 mg/kg before wound closure was effective in prevention of
postoperative shivering after open and laparoscopic cholecys-
tectomy without increasing the side effects.
M. Mohta [13] used tramadol concentrations of 1, 2 and
3 mg/kg at the time of wound closure in patients who under-
went elective abdominal operations under general anesthesia,
which was an effective antishivering agent compared to pethi-
dine 0.5 mg/kg.
Heidari et al. [15] reported that oral tramadol 50 mg as a
premedication was effective in the prevention of postanesthetic
shivering after general anesthesia, 5 patients (12.5%) hadTable 5 Mean arterial blood pressure. Data are presented as mean
Variable S (n= 30)
Preinduction 87.76 ± 6.97
15 min 76.4 ± 7.49
30 min 78.83 ± 9.74
45 min 80.5 ± 7.83
60 min 77.2 ± 5.95
75 min 78.96 ± 7.48
90 min 79.06 ± 6.35
105 min 82.2 ± 5.21
PACU
0 min 83.96 ± 8.79
30 min 85.2 ± 7.40
60 min 85.46 ± 5.81
90 min 82.66 ± 6.06
120 min 82.8 ± 11.29
Group S: received 10 ml normal saline IV.
Group H: received IV hydrocortisone 2 mg/kg.
Group T: received IV tramadol hydrochloride 1 mg/kg.
No statistically signiﬁcant difference between the study groups, P value >postanesthesic shivering in tramadol group and 10 patients
(25%) had postanesthesic shivering in the placebo group.
The incidence of grade III and grade IV shivering was 7.5%
and 25% in tramadol and placebo groups, respectively.
Heid et al. [16] reported that compared with placebo, intra-
operative intravenous administration of tramadol in a dose of
2 mg/kg 45–30 min before skin closure reduced the incidence
and severity of postoperative shivering in patient undergoing
lumbar disk surgery.
The incidence of shivering in tramadol group was 20% ver-
sus. 70% in placebo group, and severe shivering occurred in
10% in tramadol group versus 46.7% in placebo group.
Tramadol inhibits the neuronal reuptake of norepinephrine
and 5-hydroxytrytpamine, facilitates the release of 5-
hydroxytrytpamine, and activates l-opioid receptors, these
effects may inﬂuence thermoregulatory control, and the atten-
uating effect of tramadol on shivering may be due to the addi-
tive or synergistic action of kappa opioid receptor and a2
adrenergic mechanisms [17].
Pawar et al. reported that hydrocortisone 1–2 mg/kg iv was
effective in prevention of postoperative shivering after knee
arthroscopy under general anesthesia [9].± SD.
H (n= 30) T (n= 30)
89.56 ± 5.04 84.63 ± 6.84
79.46 ± 6.34 77.73 ± 6.68
80.3 ± 10.76 79 ± 9.68
79.7 ± 11.32 82.13 ± 3.48
78 ± 4.98 76.26 ± 4.61
78.46 ± 6.03 77.33 ± 6.09
78.83 ± 10.67 81.4 ± 7.51
81.9 ± 12.35 79.5 ± 11.83
80.26 ± 10.07 84.2 ± 7.24
83.53 ± 8.83 84.96 ± 6.93
83.23 ± 8.48 84.23 ± 7.72
81.56 ± 7.01 83.7 ± 5.79
80.76 ± 10.45 84.2 ± 7.59
0.05.
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effective in treating shivering after spinal anesthesia in cesar-
ean section.
The mechanism by which hydrocortisone prevents shivering
is not known [9]. A previous animal study showed that gluco-
corticoids have an anabolic effect with an increase in the levels
of hepatic ATP [19].
A study by Yared et al. [20] concluded that the incidence of
shivering after cardiac surgery was reduced by dexamethasone
due to modiﬁcation of the inﬂammatory response and the
reduction of the gradient between core and skin temperatures.
Murphy et al. [21] also concluded that the use of dexam-
ethasone before induction of general anesthesia reduced the
incidence of postoperative shivering in ICU in patients under-
going elective cardiac surgery.
Hosseinzadeh et al. [22] showed that administration of
hydrocortisone and dexamethasone before induction of gen-
eral anesthesia signiﬁcantly decreases the rate and severity of
postanesthesia shivering through anti inﬂammatory mecha-
nisms and reduction of central and skin gradient by these
drugs.
6. Conclusion
Preoperative hydrocortisone and tramadol were effective in
attenuation of postoperative shivering compared to placebo
after percutaneous nephrolithotripsy without increasing the
incidence of side effects.
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